Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aijaz Parray

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
Vaccines|October 26, 2021
SnoRNAs and miRNAs Networks Underlying COVID-19 Disease SeverityAijaz Parray, Fayaz Ahmad Mir, Asmma Doudin, et al.
Frontiers in Immunology|December 30, 2021
Complement C5a and Clinical Markers as Predictors of COVID-19 Disease Severity and Mortality in a Multi-Ethnic PopulationFarhan S Cyprian, Muhammad Suleman, Ibrahim Abdelhafez, et al.
Frontiers in Neurology|December 18, 2023
Profiling the autoantibody repertoire reveals autoantibodies associated with mild cognitive impairment and dementiaHanan Ehtewish, Areej Mesleh, Georgios Ponirakis, et al.
Frontiers in Immunology|February 6, 2023
Circulating exosomal immuno-oncological checkpoints and cytokines are potential biomarkers to monitor tumor response to anti-PD-1/PD-L1 therapy in non-small cell lung cancer patientsShayista Akbar, Afsheen Raza, Reyad Mohsin, et al.
International Journal of Molecular Sciences|May 13, 2023
Blood-Based Proteomic Profiling Identifies Potential Biomarker Candidates and Pathogenic Pathways in DementiaHanan Ehtewish, Areej Mesleh, Georgios Ponirakis, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
Vaccines|October 26, 2021
SnoRNAs and miRNAs Networks Underlying COVID-19 Disease SeverityAijaz Parray, Fayaz Ahmad Mir, Asmma Doudin, et al.
Frontiers in Immunology|December 30, 2021
Complement C5a and Clinical Markers as Predictors of COVID-19 Disease Severity and Mortality in a Multi-Ethnic PopulationFarhan S Cyprian, Muhammad Suleman, Ibrahim Abdelhafez, et al.
Frontiers in Neurology|December 18, 2023
Profiling the autoantibody repertoire reveals autoantibodies associated with mild cognitive impairment and dementiaHanan Ehtewish, Areej Mesleh, Georgios Ponirakis, et al.
Frontiers in Immunology|February 6, 2023
Circulating exosomal immuno-oncological checkpoints and cytokines are potential biomarkers to monitor tumor response to anti-PD-1/PD-L1 therapy in non-small cell lung cancer patientsShayista Akbar, Afsheen Raza, Reyad Mohsin, et al.
International Journal of Molecular Sciences|May 13, 2023
Blood-Based Proteomic Profiling Identifies Potential Biomarker Candidates and Pathogenic Pathways in DementiaHanan Ehtewish, Areej Mesleh, Georgios Ponirakis, et al.
Pageof 5